Your browser doesn't support javascript.
loading
A novel germline mutation of PDGFR-ß might be associated with clinical response of colorectal cancer to regorafenib.
Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A.
Affiliation
  • Rechsteiner M; Institute of Surgical Pathology.
  • Wild P; Institute of Surgical Pathology.
  • Kiessling MK; Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Bohnert A; Institute of Surgical Pathology.
  • Zhong Q; Institute of Surgical Pathology.
  • Stahel RA; Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Moch H; Institute of Surgical Pathology.
  • Curioni-Fontecedro A; Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: alessandra.curioni@usz.ch.
Ann Oncol ; 26(1): 246-248, 2015 Jan.
Article in En | MEDLINE | ID: mdl-25336117
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / Rectal Neoplasms / Adenocarcinoma / Receptor, Platelet-Derived Growth Factor beta / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / Rectal Neoplasms / Adenocarcinoma / Receptor, Platelet-Derived Growth Factor beta / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article